SS
Sid Shenai
Translational Research Advisor at Institute for Protein Design
Boston, Massachusetts
Overview
Sid Shenai is an accomplished Investor and Company Builder currently serving as a Venture Partner at Madrona Venture Group in Seattle, Washington. With a background that includes roles such as Co-Founder and CEO of Proof Diagnostics, Inc., he has a strong track record of success in the medical devices and biotech sectors, focusing on pre-seed and seed stage investments.
Shenai holds an impressive educational background with a Master of Business Administration and Doctor of Law from Harvard, and has leveraged his expertise to advise organizations like Ginkgo Bioworks, Inc. and the Institute for Protein Design at the University of Washington, showcasing his ability to drive innovation and growth in the companies he works with.
Work Experience
Venture Partner
2019 - Current
Visiting Scholar
2024
Translational Research Advisor
2018
Advisor
2023 - 2023
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Raised $1,575,403,063.00 from Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention and Agriculture and Food Research Initiative.
Co-Founder, CEO & Director
2020 - 2023
Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Raised $45,000,000.00 from F-Prime Capital, Madrona and ARCH Venture Partners.
Affiliate Researcher
2018 - 2023
Portfolio Manager, Head of Rates
2010 - 2017
Bracebridge manages assets for a diverse, sophisticated, global investor base that includes endowments, foundations, pensions, and high net.
Business Analyst
2004 - 2006
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity